Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Rajendra V. Deshpande is active.

Publication


Featured researches published by Rajendra V. Deshpande.


Journal of Cellular Biochemistry | 1997

GRANULOCYTE COLONY-STIMULATING FACTOR-INDUCED ACTIVATION OF PROTEIN KINASE-C IN MYELOID CELLS

Rajendra V. Deshpande; Robert H. F. Peterson; Malcolm A. S. Moore

Granulocyte colony stimulating factor (G‐CSF) regulates survival, proliferation, differentiation, and activation of myeloid cells. It binds to a high affinity receptor (G‐CSF‐R) expressed on myeloid cells, for which the signal transduction mechanisms other than protein tyrosine kinase (PTK) activation have not been completely identified. We explored the potential involvement of protein kinase‐C (PKC) in G‐CSF‐R signal transduction. In this report, we provide direct evidence of PKC activation by G‐CSF‐R. G‐CSF treatment of peripheral blood neutrophils, granulocytic cell lines (HL‐60, NFS‐60, KG‐1), and monocytic cell lines (WEHI‐3B,U‐937) resulted in PKC activation. Chelerythrine chloride and HA‐100, an isoquinolinesulfonamide derivative, the specific inhibitors of PKC, 1,2‐Bis(2‐aminophenoxy)ethane‐N,N,N′,N′‐tetra‐acetic acid (BAPTA), a chelator of intracellular calcium, and 3,4,5‐trimethoxybenzoic acid 8‐(diethylamino)‐octyl ester (TMB‐8), an inhibitor of intracellular calcium release, blocked G‐CSF‐induced PKC activation in HL‐60 cells, and reduced CD11b upregulation in neutrophils, but did not affect ligand‐binding or down‐modulation of G‐CSF‐R. Methyl 2,5‐dihydroxycinnamate (MDHC), a potent inhibitor of protein tyrosine kinases (PTK), also inhibited PKC activation in response to G‐CSF treatment, suggesting that PKC activation may occur downstream of PTK activation. Our results demonstrate the involvement of PKC in G‐CSF‐R signal transduction, and suggest a common signaling pathway in myeloid cells of granulocytic and monocytic lineages. J. Cell. Biochem. 66:286–296, 1997.


Archive | 2005

Compositions and Methods Relating to Anti-IGF-1 Receptor Antibodies

Frank J. Calzone; Rajendra V. Deshpande; Mei-Mei Tsai


Archive | 2001

Fully human antibody Fab fragments with human interferon-gamma neutralizing activity

Rajendra V. Deshpande; Mei-Mei Tsai


Archive | 2001

Selective binding agents of osteoprotegerin binding protein

Rajendra V. Deshpande; Anna Hitz; William J. Boyle; John K. Sullivan


Archive | 2001

Antagonistic selective binding agents of osteoprotegerin binding protein

William J. Boyle; Rajendra V. Deshpande; Anna Hitz; John K. Sullivan


Archive | 2005

Compositions comprising anti-IGF-1R Antibodies and Methods for obtaining said Antibodies

Frank J. Calzone; Rajendra V. Deshpande; Mei-Mei Tsai


Archive | 2007

COMPOSICIONES Y PROCEDIMIENTOS REFERIDOS A ANTICUERPOS CONTRA EL RECEPTOR DE IGF-1

Frank J. Calzone; Rajendra V. Deshpande; Mei-Mei Tsai


Archive | 2005

Compositions conprenant anti-IGF-1R anticorps et méthodes pour leur production

Frank J. Calzone; Rajendra V. Deshpande; Mei-Mei Tsai


Archive | 2005

Zubereitungen die anti-IGF-1R Antiköper enthalten und Verfahren für deren Produktion

Frank J. Calzone; Rajendra V. Deshpande; Mei-Mei Tsai


Archive | 2005

Compositions et procedes impliquant des anticorps diriges contre le recepteur igf-1r

Frank J. Calzone; Rajendra V. Deshpande; Mei-Mei Tsai

Collaboration


Dive into the Rajendra V. Deshpande's collaboration.

Top Co-Authors

Avatar

Malcolm A. S. Moore

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Robert H. F. Peterson

Memorial Sloan Kettering Cancer Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge